HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

N- (4- (3- (1H- 1,2,4- triazol- 1- yl)- 4- (3,4,5- trimethoxybenzoyl)phenyl)thiazol- 2- yl)- 2- amino- 3- methylbutanamide

an antineoplastic agent; a prodrug of S-516; structure in first source
Also Known As:
CKD 516; CKD-516; CKD516
Networked: 7 relevant articles (3 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Lee, Jeong Min: 5 articles (01/2016 - 10/2013)
2. Choi, Byung Ihn: 4 articles (01/2016 - 10/2013)
3. Han, Joon Koo: 4 articles (01/2016 - 10/2013)
4. Joo, Ijin: 3 articles (01/2016 - 01/2014)
5. Park, Jisuk: 2 articles (04/2014 - 10/2013)
6. Kim, Kyung Won: 2 articles (04/2014 - 10/2013)
7. Kim, Soo Jin: 2 articles (04/2014 - 09/2010)
8. Kim, Dal-Hyun: 2 articles (04/2014 - 09/2010)
9. Grimm, Robert: 1 article (01/2016)
10. Min, Young Joo: 1 article (06/2014)

Related Diseases

1. Neoplasms (Cancer)
2. Hepatocellular Carcinoma (Hepatoma)
3. Necrosis

Related Drugs and Biologics

1. Doxorubicin (Adriamycin)
2. Tubulin
3. contrast agent BR1
4. gemcitabine

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Aftercare (After-Treatment)
3. Drug Therapy (Chemotherapy)